What is the relationship between cirrhosis and portal hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Cirrhosis is the most common cause of portal hypertension.

Relationship Between Cirrhosis and Portal Hypertension

  • Portal hypertension is a common clinical syndrome characterized by a pathological increase in portal pressure and the formation of portal-systemic collaterals that bypass the liver 1.
  • The most common cause of portal hypertension is cirrhosis, which leads to increased intrahepatic vascular resistance and portal blood flow 1.
  • Cirrhosis can lead to portal hypertension due to architectural distortion of the liver secondary to fibrous tissue and regenerative nodules, as well as active intrahepatic vasoconstriction 1.
  • The increased portal pressure gradient results from both an increase in resistance to portal flow (intrahepatic and collateral) and an increase in portal blood inflow 1.
  • Portal hypertension can lead to various complications, including ascites, dilutional hyponatremia, refractory ascites, hepatorenal syndrome (HRS), and spontaneous bacterial peritonitis 1.
  • The gold-standard test for portal hypertension is the measurement of hepatic venous pressure gradient (HVPG) 1.

From the Research

Relationship Between Cirrhosis and Portal Hypertension

The relationship between cirrhosis and portal hypertension is well-established, with portal hypertension being a major complication of cirrhosis 2, 3.

  • Cirrhosis frequently leads to the development of portal hypertension, which can cause substantial morbidity and mortality 3.
  • Portal hypertension is characterized by increased pressure in the portal vein, which can lead to complications such as ascites, esophageal varices, hepatic encephalopathy, and hepatorenal syndrome 2.
  • The pathophysiology of portal hypertension in cirrhosis involves the formation of structurally abnormal nodules in the liver, leading to increased resistance to blood flow and subsequent increased pressure in the portal vein 3.

Clinical Manifestations

The clinical manifestations of portal hypertension in cirrhosis include:

  • Gastroesophageal varices and ascites, which are two of the most common complications of portal hypertension 3.
  • Hepatic encephalopathy, which is a condition characterized by cognitive impairment and altered mental status 2.
  • Portal hypertensive gastropathy (PHG), which is a condition characterized by mucosal lesions in the stomach due to increased portal pressure 4.

Diagnosis and Treatment

The diagnosis and treatment of portal hypertension in cirrhosis involve:

  • Measurement of hepatic venous pressure gradient (HVPG) to assess the severity of portal hypertension 4.
  • Use of nonselective beta-blockers to reduce portal pressure and prevent complications such as variceal bleeding 5.
  • Treatment of underlying liver disease, such as cirrhosis, to prevent progression of portal hypertension 5.

Pathophysiology

The pathophysiology of portal hypertension in cirrhosis is complex and involves:

  • Intimal thickening of the portal vein, which is associated with indicators of portal hypertension 6.
  • Increased resistance to blood flow in the liver, leading to increased pressure in the portal vein 3.
  • Local inflammatory responses, which may contribute to the development of portal hypertension 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacologic Treatment of Portal Hypertension.

Clinics in liver disease, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.